BRIAN GAYNOR: ASX investors want our growth companies

BRIAN GAYNOR: ASX investors want our growth companies
Aroa ceo Brian Ward rings the bell at listing on the ASX in June
Brian Gaynor
Ryman Healthcare shareholders were taken aback this week by a couple of short replies to the following question: “Does the company intend to seek a listing on the ASX?”.Chief executive Gordon MacLeod answered “No” while chairman David Kerr told annual meeting attendees: “Not at this time. We have contemplated dual listing but we are not – that’s not an active discussion at the moment.”Why is Ryman unenthusiastic about an NZX/ASX dual listing when 14 of the largest 20 NZX companies are also listed...

More Opinion

Benchmark-beaters: how ESG gives indexers active power
Opinion

David Chaplin: Benchmark-beaters: how ESG gives indexers active power

The ESG push among institutional investors is changing the mix.

David Chaplin 03 Jul 2024
Has ArborGen finally crossed the Rubicon?
Opinion

Paul McBeth: Has ArborGen finally crossed the Rubicon?

Long-suffering shareholders might be dubious about the emerging green shoots.

Paul McBeth 02 Jul 2024
Our nation of tinkerers
Opinion

Simon Robertson: Our nation of tinkerers

From wine to Wētā, New Zealanders are always excelling at something.  

Simon Robertson 29 Jun 2024
How to protect your business's brand
Opinion

Georgina Toomey: How to protect your business's brand

Monitor anyone using your trademarks to protect it. 

Georgina Toomey 27 Jun 2024